Botox: Shaken, not stirred

Ophthalmic Plastic and Reconstructive Surgery

Volumn 24, Issue 1, 2008, Pages 10-12

  Kazim, Nadia A ^a   Black, Evan H ^a  

^a WAYNE STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BOTULINUM TOXIN A;

ADULT; ARTICLE; CONTROLLED STUDY; DRUG INFORMATION; DRUG MIXTURE; DRUG PACKAGING; EYEBROW; FEMALE; FOREHEAD; HUMAN; MALE; NORMAL HUMAN; PLASTIC SURGERY; PRIORITY JOURNAL;

ADULT; BOTULINUM TOXIN TYPE A; CHEMISTRY, PHARMACEUTICAL; DOUBLE-BLIND METHOD; EYEBROWS; FACIAL MUSCLES; FEMALE; HUMANS; INJECTIONS; MALE; NEUROMUSCULAR AGENTS; PHARMACEUTICAL PREPARATIONS; PROSPECTIVE STUDIES; SKIN AGING;

EID: 38349177281     PISSN: 07409303     EISSN: None     Source Type: Journal    
DOI: 10.1097/IOP.0b013e3181607475     Document Type: Article

References (10)

1. Carruthers A, Carruthers J. Clinical indications and injection technique for the cosmetic use of botulinum A exotoxin. Dermatol Surg 1998;24:1189-94.
2. Carruthers J, Fagien S, Matarasso SL; Botox Consensus Group. Consensus recommendations on the use of botulinum toxin type a in facial aesthetics. Plast Reconstr Surg 2004;114(6 Suppl):1S-22S.
3. Carter SR, Seiff SR. Cosmetic botulinum toxin injections. Int Ophthalmol Clin 1997;37:69-79.
4. Fagien S, Brandt FS. Primary and adjunctive use of botulinum toxin type A (Botox) in facial aesthetic surgery: beyond the glabella. Clin Plast Surg 2001;28:127-48.
5. Product literature (package insert) on Botox. Irvine, CA: Allergan, Inc., 2002.
6. Charles PD. Botulinum neurotoxin serotype A: a clinical update on non-cosmetic uses. Am J Health Syst Pharm 2004;61(22 Suppl 6):S11-S23.
7. Huang W, Foster JA, Rogachefsky AS. Pharmacology of botulinum toxin. J Am Acad Dermatol 2000;43(2, Pt 1):249-59.
8. Anderson ER Jr. Proper dose, preparation, and storage of botulinum neurotoxin serotype A. Am J Health Syst Pharm 2004;61(22 Suppl 6):S24-S29.
9. Klein AW. Dilution and storage of botulinum toxin. Dermatol Surg 1998;24:1179-80.
10. Trindade De Almeida AR, Kadunc BV, Di Chiacchio N, Neto DR. Foam during reconstitution does not affect the potency of botulinum toxin type A. Dermatol Surg 2003;29:530-1; discussion 532.